INTEGRATED CORE STRATEGIES (US) LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share
Symbol
RVPH
Shares outstanding
116,345,357 shares
Disclosed Ownership
3,257,670 shares
Ownership
2.8%
Form type
SCHEDULE 13G/A
Filing time
16 Jan 2026, 16:52:04 UTC
Date of event
31 Dec 2025
Next filing
30 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 2.8% ownership in Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH) on 31 Dec 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH).
  • Disclosed ownership: 2.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 Jan 2026, 16:52.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 2.8% 3,254,631 0 3,254,631 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 2.8% 3,257,670 0 3,257,670 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 2.8% 3,257,670 0 3,257,670 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 2.8% 3,257,670 0 3,257,670 /s/ Israel A. Englander Israel A. Englander

Sponsored